Evaluation of filovirus vaccines in a general use prophylaxis (GUP) immunogenicity and ebolavirus challenge studies to identify potential correlates of protection (task area 3)

Ended Awarded Last action

Contract number
HHSN27200014
Awardee
Awarding agency
Obligated
$7,274,594

Award facts

Contract value 100% obligated
  • $7,274,594.29 Current, with exercised options
  • $7,299,201.29 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Award Fee
Place of performance
Columbus, OH 43201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 $325,862
Other Administrative Action P00012 $0
Funding Only Action P00011 $0
Supplemental Agreement for work within scope P00010 -$1,340,084
Supplemental Agreement for work within scope P00009 $0
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope 6 $0
Supplemental Agreement for work within scope 5 $0
Supplemental Agreement for work within scope 4 $89,265
Supplemental Agreement for work within scope 3 -$130,872
Supplemental Agreement for work within scope 2 -$769,671
Exercise an Option 1 $157,455
Original award $8,942,639
Show all 14

About this award

Battelle Memorial Institute was awarded a $7,299,201 cost-plus-award-fee delivery order contract by the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases. The contract calls for Battelle to conduct evaluation of filovirus vaccines in general use prophylaxis immunogenicity and Ebola virus challenge studies to identify potential correlates of protection, with a period of performance through December 2023. Envigo Global Services Inc., the University of Texas System, and the Texas Biomedical Research Institute were identified as major subcontractors to provide non-human primates, testing, transportation, and research services. No set-aside designation was specified. The award draws on Battelle's experience conducting evaluation and testing services for vaccines and other biologics for infectious diseases through existing contracts with HHS agencies.

Quick answers

Who was awarded contract HHSN27200014?

HHSN27200014 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 9, 2015.

How much is contract HHSN27200014 worth?

The government has obligated $7,274,594 on HHSN27200014. Its potential value, with all options, is $7,299,201.

Is contract HHSN27200014 an order under another contract?

Yes. HHSN27200014 is a delivery order under HHSN272201200003I, an indefinite delivery contract.

Was contract HHSN27200014 competed?

The extent of competition for HHSN27200014 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award